SARS-CoV-2 S1 Monoclonal antibody 

To Order Contact us: stephen@expresspharmapulse.com

Human CellExp™ SARS-CoV-2 Spike Protein (S1), Recombinant

P1531-50 50 µg Ask for price

Recombinant Coronavirus Spike Protein (SARS-CoV S1; His tag)

P1516-10 10µg
EUR 257

SARS CoV-2 PCR kit

PCR-H731-48R 48T
EUR 823

SARS CoV-2 PCR kit

PCR-H731-96R 96T
EUR 1113

Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2; S1), Recombinant

P1524-10 10 µg
EUR 277

SARS S1 [His]

DAG1861 500 ug
EUR 2529

Human CellExp™ SARS-CoV-2 Spike Protein (S1; His-tag), Recombinant

P1532-10 10 µg
EUR 156

Human CellExp™ SARS-CoV-2 Spike Protein (S1; His-tag), Recombinant

P1532-50 50 µg
EUR 551

SARS CoV E Protein

abx060650-1mg 1 mg
EUR 1692

SARS CoV Nucleocapsid Protein

abx060652-1mg 1 mg
EUR 1873

SARS-CoV Nucleocapsid Protein

abx060653-1mg 1 mg
EUR 1692

SARS-CoV Nucleocapsid Protein

abx060654-1mg 1 mg
EUR 1692

SARS-CoV Spike Protein

abx060655-1mg 1 mg
EUR 1692

SARS-CoV spike protein Antibody

abx023139-100ug 100 ug
EUR 857

SARS-CoV spike protein Antibody

abx023143-100ug 100 ug
EUR 857

SARS-CoV-2 IgG ELISA Kit

E4901-100 100 assays
EUR 753

Recombinant Coronavirus Nucleoprotein (SARS-CoV-2)

P1523-10 10 µg
EUR 156

Recombinant Coronavirus Nucleoprotein (SARS-CoV-2)

P1523-50 50 µg
EUR 551

SARS CoV-2 RT PCR kit

RTq-H731-100R 100T
EUR 1311

SARS CoV-2 RT PCR kit

RTq-H731-150R 150T
EUR 1787

SARS CoV-2 RT PCR kit

RTq-H731-50R 50T
EUR 963

SARS-CoV-2 Antigen ELISA Kit

DEIA2020 96 tests
EUR 905
Description: SARS-CoV-2 Antigen ELISA Kit intended use is for quantitative detection of the recombinant SARS-COV-2 nucleoprotein antigen in human serum. The use of this kit for natural samples need to be validated by the end user due to the complexity of natural targets and unpredictable interference.

Anti-SARS-CoV-2 Antibody (Clone# 6F10)

A2060-50 50 µg
EUR 480

Anti-SARS-CoV-2 NP Antibody (Clone# 11D5)

A2092-50 50 µg
EUR 480

Anti-SARS-CoV-2 NP Antibody (Clone# 4G1)

A2093-50 50 µg
EUR 480

SARS-CoV-2 Nucleoprotein IgG Antibody ELISA Kit

E4821-100 96 assays
EUR 1057

Recombinant SARS-CoV-2 Nucleoprotein (1-430)

P1537-10 10 µg
EUR 156

Recombinant SARS-CoV-2 Nucleoprotein (1-430)

P1537-50 50 µg
EUR 530

Recombinant SARS-CoV-2 Nucleoprotein (1-430)

P1539-10 10 µg
EUR 156

Recombinant SARS-CoV-2 Nucleoprotein (1-430)

P1539-50 50 µg
EUR 530

Recombinant SARS-CoV-2 3C-like Proteinase

P1550-10 10 μg
EUR 156

Recombinant SARS-CoV-2 3C-like Proteinase

P1550-50 50 μg
EUR 551

Recombinant SARS-CoV-2 Papain-like Protease

P1551-10 10 μg
EUR 156

Recombinant SARS-CoV-2 Papain-like Protease

P1551-50 50 μg
EUR 551

Coronavirus (SARS-CoV-2) PCR Detection Kit

K1460-100 100 Rxns Ask for price

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-1 1T
EUR 8
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again.

SARS-CoV-2 Rapid Antigen Test Nasal

9901-NCOV-03G 25 Tests/Kit
EUR 94
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

SARS-CoV-2 S1 Monoclonal antibody